2nd Annual Gene Therapy for Rare Disorders Europe

2nd Annual Gene Therapy for Rare Disorders Europe is organized by Hanson Wade and will be held from Oct 22 - 24, 2018 at Hotel Novotel London West, London, England, United Kingdom.

Overcoming Analytical Challenges Encountered Throughout the Development of Gene Therapies Pre-Conference Workshop will be held on Oct 22, 2018.

The target audience for this medical event is professionals that are already involved or about to embark in the gene therapy space.

Conference Description :
Gene Therapy for Rare Disorders Europe is the uniquely focused conference uniting industry leaders to discuss the late-stage challenges that need to be overcome to deliver more gene therapies to market.

Now is a crucial time for the gene therapy field, as the ripple effects of the pioneering first US gene therapy approval are being felt globally, setting new benchmarks and posing unexpected questions.

Gene Therapy for Rare Disorders Europe is the uniquely focused conference that will bring the leaders in this field together to discuss the critical factors involved in driving commercial success for gene therapies in the complex European landscape.

Bringing together leading experts from innovative biotechs, large pharma, payers, investors and academics, this conference will present a comprehensive insight into the cutting edge progress of gene therapies combatting the rare disease.

Rather than early-stage basic science, this meeting is solely devoted to addressing the latest clinical, manufacturing, regulatory and commercialization challenges facing this rapidly evolving field. This is a comprehensive guide to define your commercial path forward.

Additional details will be posted as soon as they are available.